takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Tadataka Yamada M.D.
Chief Medical & Scientific Officer and Director, Takeda Pharmaceutical Company Limited
|Age||Total Calculated Compensation||This person is connected to 134 board members in 8 different organizations across 11 different industries.|
See Board Relationships
Dr. Tadataka Yamada, Tachi, has been Corporate Officer and Head of Emerging Markets Commercial Operations for Nycomed A/S at Takeda Pharmaceutical Company Limited. Dr. Yamada served as an Executive Vice President and Medical and Scientific Advisor to the Chief Executive Officer of Takeda Pharmaceutical Company Limited. Dr. Yamada serves as an Executive Vice President and Medical and Scientific Advisor to the CEO at Takeda Pharmaceuticals International Inc. He was a Senior ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Former Director and Member of Audit Coommittee
Executive Vice President, Medical & Scientific Advisor to the Chief Executive Officer and Director
Former Chairman of Research & Development, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Financial Results Committee
Former Director, Member of Compliance Committee and Member of Nominating & Governance Committee
Director, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee
Chief Medical & Scientific Officer and Director
The Board of Trustees of The Leland Stanford Junior University
New York University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Lars Rebien Sørensen||Chief Executive Officer, President and Member of the Senior Management Board|
Novo Nordisk A/S
|Karl-Ludwig Kley||Chairman of the Executive Board and General Partner|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|--||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26